Five Prime Therapeutics, Inc.: 25-NSE filed Apr 16, 2021

Form type

25-NSE

Filing date

Apr 16, 2021

Accession number

0001354457-21-000482

Filer

Five Prime Therapeutics, Inc. (CIK 1175505)